CClinicalTrials.gg
Status unknownNCT05068297Updated Oct 25, 2021

The Impact of Germanium-Embedded Knee Brace on Patient Recovery After ACL Reconstruction

An interventional study of Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction and Replica Knee Brace in Anterior Cruciate Ligament Injuries, sponsored by Total Sports Medicine & Orthopedics. Status unknown. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-10-25.

Sponsored by Total Sports Medicine & Orthopedics · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Anti-inflammatory brace technology has demonstrated superior clinical outcomes in the management of knee osteoarthritis and accelerate recovery time for Major League Soccer players. Authors have postulated that embedding germanium into cotton garments increases circulation and augments the inflammatory process through a transdermal micro-electromagnetic field. In addition to immunomodulatory effects, knee braces immobilize and stabilize the joint through tactile feedback from the skin. Thus, a germanium-embedded knee brace may provide inflammatory control to augment pain and edema while concomitantly enhancing proprioception. ACL Reconstruction rehabilitation goals during the acute post-operative phase include diminishment of pain and edema as well as restoration of knee range-of-motion. The presented study intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction.

Single-center blinded randomized controlled clinical trial to study effectiveness of germanium-infused knee brace on rehabilitation in patient population undergoing ACL reconstruction. Patients will be randomized into germanium-infused knee brace group and compared to a replica knee brace group. Inclusion criteria will include skeletally mature individuals undergoing primary ACL reconstruction. Exclusion criteria will include autoimmune disorders and history of surgery on ipsilateral joint. The presented protocol intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction. The primary outcome measure was chosen for its implications for the design and conduct of the study,1 including well-validated outcome instrument for comparison, facilitation of a priori power analysis, randomization, and blinding. Secondary outcomes were chosen for their pertinence to surgeon decision-making during patient rehabilitation.

02

Conditions studied

  • Anterior Cruciate Ligament Injuries
03

In context

Anterior Cruciate Ligament Injuries

512 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 164 are open to participants now.

This study's planned enrollment of 100 is above the median of 56 across 373 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Total Sports Medicine & Orthopedics is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18-100 years old
  • Male or female
  • Compliant patient
  • BMI less than 35
  • Undergoing ACL reconstruction within 30 days

Exclusion criteria

Exclusion Criteria:

  • Rheumatoid Arthritis
  • Poorly controlled diabetes (HgA1c > 7.5)
  • Previous blood clots
  • BMI greater than 35
  • Varicosities on operative leg
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Germanium-Embedded Knee Brace

    Following surgery the patients effected limb would be placed in an Germanium-Embedded Knee Brace

    Other: Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction

  • Active comparator
    Replica Knee Brace

    Following surgery the patients effected limb would be placed in a replica knee brace

    Other: Replica Knee Brace

Interventions

  • OtherIncrediwear Germanium-Embedded Knee Brace following ACL reconstruction

    Germanium-Embedded Knee Brace will be applied to the effected limb following ACL reconstruction

  • OtherReplica Knee Brace

    Replica Knee brace will be applied to the effected limb following ACL reconstruction

06

What researchers measure

Primary outcomes

  1. Short Form 36 (SF-36)

    A well-validated patient reported outcome and the most commonly used outcome instrument in orthopaedics.

    Time frame: 4 weeks

Secondary outcomes

  1. Pain Estimation

    Visual Analog Scale

    Time frame: 6 weeks

  2. Leg Circumference

    In centimeters, measure by senior surgeon during physical exam using a tape measure at standard post-operative visits

    Time frame: 6 weeks

  3. Knee Range of Motion

    In degrees, measured by a senior surgeon using a Goniometer, at standard post-operative visits

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05068297
Lead sponsor
Total Sports Medicine & Orthopedics
Responsible party
Sponsor
First posted
Oct 5, 2021
Start date
Nov 2021 (estimated)
Primary completion
Sep 1, 2022 (estimated)
Completion
Oct 1, 2022 (estimated)
Last update
Oct 25, 2021

Study contacts

Shanthan C Challa, MD
Contact
shanthancchalla@gmail.com
7024998579
Roddy McGee
Contact

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion